Compare ARK Genomic Revolution ETF (ARKG) vs Crown Castle International Corp (CCI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Crown Castle International Corp — how do they compare? ARK Genomic Revolution ETF trades at $41, while Crown Castle International Corp trades at $80 (market cap $34.77B). The key difference: Crown Castle International Corp pays a 5.34% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Crown Castle International Corp nearer its low. Which is the better fit depends on your goals.
| ARKG | CCI | |
|---|---|---|
Sector | Sector/Thematic | Real Estate |
52-Week High | $43.57 | $113.91 |
52-Week Low | $23.09 | $74.92 |
Market Cap | — | $34.77B |
Enterprise Value | — | $64.59B |
Dividend Yield | — | 5.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Crown Castle (CCI) trades at $79.66, up 3.89% today, but remains in a bearish technical trend with weak moving averages. The company reported mixed Q1 2026 earnings, missing EPS estimates, while revenue declined to $4.26B in 2025. Analyst consensus is divided with a $97.33 price target, and the stock offers a 5.55% dividend yield. Recent news highlights strategic shifts to a pure-play tower focus amid leadership changes.
Outlook is cautious due to high debt levels and competitive pressures, but long-term value exists if operational improvements materialize. Key risks include interest rate sensitivity and execution challenges. Investors should weigh the dividend appeal against fundamental headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Crown Castle International Corp
Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.
Read more on CCI →
